These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25846622)

  • 21. Proteinases as hormone-like signal messengers.
    Hollenberg MD; Houle S
    Swiss Med Wkly; 2005 Jul; 135(29-30):425-32. PubMed ID: 16208579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiological actions of protease activated receptors (PARs).
    Pandya NM; Jain SM; Santani DD
    Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more.
    Hollenberg MD
    Life Sci; 2003 Dec; 74(2-3):237-46. PubMed ID: 14607251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
    Luo W; Wang Y; Reiser G
    Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Getting the message across: pathophysiology and signaling via receptors for polypeptide hormones and proteinases.
    Hollenberg MD
    Clin Invest Med; 2010 Apr; 33(2):E133. PubMed ID: 20370993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
    Arora P; Ricks TK; Trejo J
    J Cell Sci; 2007 Mar; 120(Pt 6):921-8. PubMed ID: 17344429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-activated receptors and itch.
    Akiyama T; Lerner EA; Carstens E
    Handb Exp Pharmacol; 2015; 226():219-35. PubMed ID: 25861783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation signalling following tissue injury: focus on the role of factor Xa.
    Krupiczojc MA; Scotton CJ; Chambers RC
    Int J Biochem Cell Biol; 2008; 40(6-7):1228-37. PubMed ID: 18420447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinase-activated receptors in fibroproliferative lung disease.
    José RJ; Williams AE; Chambers RC
    Thorax; 2014 Feb; 69(2):190-2. PubMed ID: 24186921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
    Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
    Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiology and pathophysiology of proteinase-activated receptors (PARs): PARs in the respiratory system: cellular signaling and physiological/pathological roles.
    Kawabata A; Kawao N
    J Pharmacol Sci; 2005 Jan; 97(1):20-4. PubMed ID: 15655298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shooting for PARs in lung diseases.
    Moffatt JD; Page CP; Laurent GJ
    Curr Opin Pharmacol; 2004 Jun; 4(3):221-9. PubMed ID: 15140412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease-activated receptors: novel PARtners in innate immunity.
    Shpacovitch V; Feld M; Bunnett NW; Steinhoff M
    Trends Immunol; 2007 Dec; 28(12):541-50. PubMed ID: 17977790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinase-activated receptor pharmacology: trickier and trickier.
    Moffatt JD
    Br J Pharmacol; 2004 Oct; 143(4):441. PubMed ID: 15381632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.
    Hirano K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):27-36. PubMed ID: 17095716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Opportunities in Protease-Activated Receptor Drug Development.
    Hamilton JR; Trejo J
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():349-373. PubMed ID: 27618736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.